Skip to content
Are Speaker programs supposed to be salesy? episode artwork

Jul 4, 2025 1 min

Are Speaker programs supposed to be salesy?

from DarshanTalks Podcast Hosted by Darshan Kulkarni

Send us Fan Mail Pharmaceutical speaker programs come in two forms: one aimed at promoting a product, and another focused purely on education. Both must be compliant, but many companies blur the lines—leading to billion-dollar fines. Government bodies like the OIG consider these programs “inherently suspect” unless strict criteria are met. To stay compliant, speakers must have relevant expertise (not just high prescription rates), and every presentation is vetted by a Medical-Legal-Regulatory (MLR) team. Despite all this oversight, violations are common—and patients can report them under FDA’s Bad Ad program. Support the show www.kulkarnilawfirm.com

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Are Speaker programs supposed to be salesy?

0:00 1:31

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of DarshanTalks Podcast?

This episode is 1 minute long.

When was this DarshanTalks Podcast episode published?

This episode was published on July 4, 2025.

Can I download this DarshanTalks Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.